Top Markets
Coin of the day
BioLineRx Ltd. BioLineRx Ltd.

BioLineRx Ltd.

BLRX
Clasificación en acciones #40526
BioLineRx Ltd., a commercial stage biopharmaceutical company, develops and... BioLineRx Ltd., a commercial stage biopharmaceutical company, develops and commercializes therapeutics for oncology and rare diseases. The company's pipeline includes APHEXDA (motixafortide), a peptide that is in Phase 1 clinical trial for the treatment of sickle cell disease, and Phase 2b clinical trial for the treatment of pancreatic cancer, as well as completed Phase 3 clinical trial for the treatment of multiple myeloma. It develops BL-5010, a pen-like applicator containing an acidic aqueous solution for the non-surgical removal of skin lesions. BioLineRx Ltd. was incorporated in 2003 and is headquartered in Hevel Modi'in, Israel.
Precio por acción
$0.0048574
Capitalización bursátil
$126.82K
Cambio (1 día)
0.00%
Cambio (1 año)
-21.82%
País
IL
Comercio BioLineRx Ltd. (BLRX)

Categoría

Historial del precio de la acción de BioLineRx Ltd. (BLRX)
Precio más alto de cierre: $0.00 el 2026-08-01

Precio más bajo de cierre: $14.35 el 2007-04-01
Historial del precio de la acción de BioLineRx Ltd. desde 2007 hasta 2026
Desempeño anual del precio de la acción
Año Rendimiento
2026 (TTM) -47.74%
2025 -72.81%
2024 -82.33%
2023 140.69%
2022 -70.64%
2021 -10.07%
2020 9.62%
2019 -73.07%
2018 -47.46%
2017 15.06%
2016 -30.90%
2015 -12.27%
2014 -42.61%
2013 -0.68%
2012 -13.02%
2011 -62.49%
2010 -20.78%
2009 453.72%
2008 -83.34%
2007 0.00%
Precio de la acción de empresas similares o competidoras
Empresa Precio de la acción Cambio 1a% País
$517.18 30.63%
US
$857.76 32.66%
NL
$744.96 8.94%
CH
$1.08K -6.68%
KR
$259.89 16.65%
BE